Immunosuppressive treatment for giant cell arteritis: where do we stand?

被引：0

作者：

Pipitone, N. ^{[1
]}

Salvarani, C. ^{[1
]}

机构：

[1] Azienda Osped ASMN, Dept Internal Med, Rheumatol Unit, Ist Ricovero & Cura Carattere Sci, Reggio Emilia, Italy

来源：

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2015年 / 33卷 / 02期

关键词：

giant cell arteritis; immunosuppressive treatment; PLACEBO-CONTROLLED TRIAL; LARGE-VESSEL VASCULITIS; DOUBLE-BLIND; METHOTREXATE TREATMENT; TOCILIZUMAB; METAANALYSIS; EFFICACY; THERAPY;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S5 / S6

页数：2

共 14 条

[1]

Camellino D, 2010, CLIN EXP RHEUMATOL, V28, P288

[2] The Lifetime Risk of Adult-Onset Rheumatoid Arthritis and Other Inflammatory Autoimmune Rheumatic Diseases [J].

Crowson, Cynthia S. ;

Matteson, Eric L. ;

Myasoedova, Elena ;

Michet, Clement J. ;

Ernste, Floranne C. ;

Warrington, Kenneth J. ;

Davis, John M., III ;

Hunder, Gene G. ;

Therneau, Terry M. ;

Gabriel, Sherine E. .

ARTHRITIS AND RHEUMATISM, 2011, 63 (03) :633-639

[3] Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis - A randomized trial [J].

Hoffman, Gary S. ;

Cid, Maria C. ;

Rendt-Zagar, Karen E. ;

Merkel, Peter A. ;

Weyand, Cornelia M. ;

Stone, John H. ;

Salvarani, Carlo ;

Xu, Weichun ;

Visvanathan, Sudha ;

Rahman, Mahboob U. .

ANNALS OF INTERNAL MEDICINE, 2007, 146 (09) :621-630

[4] A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis [J].

Hoffman, GS ;

Cid, MC ;

Hellman, DB ;

Guillevin, L ;

Stone, JH ;

Schousboe, J ;

Cohen, P ;

Calabrese, LH ;

Dickler, H ;

Merkel, PA ;

Fortin, P ;

Flynn, JA ;

Locker, GA ;

Easley, KA ;

Schned, E ;

Hunder, GG ;

Sneller, MC ;

Tuggle, C ;

Swanson, H ;

Hernández-Rodríguez, J ;

Lopez-Soto, A ;

Bork, D ;

Hoffman, DB ;

Kalunian, K ;

Klashman, D ;

Wilke, WS ;

Scheetz, RJ ;

Mandell, BF ;

Fessler, BJ ;

Kosmorsky, G ;

Prayson, R ;

Luqmani, RA ;

Nuki, G ;

McRorie, E ;

Sherrer, Y ;

Baca, S ;

Walsh, B ;

Ferland, D ;

Soubrier, M ;

Choi, HK ;

Gross, W ;

Segal, AM ;

Ludivico, C ;

Puechal, X .

ARTHRITIS AND RHEUMATISM, 2002, 46 (05) :1309-1318

[5] Combined treatment of giant-cell arteritis with methotrexate and prednisone -: A randomized, double-blind, placebo-controlled trial [J].

Jover, JA ;

Hernández-García, C ;

Morado, IC ;

Vargas, E ;

Bañares, A ;

Fernández-Gutiérrez, B .

ANNALS OF INTERNAL MEDICINE, 2001, 134 (02) :106-114

[6] Clinical and biological efficacy of tocilizumab in giant cell arteritis: Report of three patients and literature review [J].

Kieffer, P. ;

Hinschberger, O. ;

Ciobanu, E. ;

Jaeger-Bizet, F. ;

Drabo, A. ;

Mostoufizadeh, T. ;

Martzolff, L. .

REVUE DE MEDECINE INTERNE, 2014, 35 (01) :56-59

[7] Adjunctive methotrexate for treatment of giant cell arteritis -: An individual patient data meta-analysis [J].

Mahr, Alfred D. ;

Jover, Juan A. ;

Spiera, Robert F. ;

Hernandez-Garcia, Cesar ;

Fernandez-Gutierrez, Benjamin ;

LaValley, Michael P. ;

Merkel, Peter A. .

ARTHRITIS AND RHEUMATISM, 2007, 56 (08) :2789-2797

[8] A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects [J].

Martinez-Taboada, V. M. ;

Rodriguez-Valverde, V. ;

Carreno, L. ;

Lopez-Longo, J. ;

Figueroa, M. ;

Belzunegui, J. ;

Mola, E. M. ;

Bonilla, G. .

ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (05) :625-630

[9]

Pazzola G, 2013, CLIN EXP RHEUMATOL, V31, pS59

[10] Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes [J].

Proven, A ;

Gabriel, SE ;

Orces, C ;

O'Fallon, WM ;

Hunder, GG .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2003, 49 (05) :703-708

← 1 2 →